Mr. Speaker, I am very pleased to rise today to congratulate my colleague on presenting Bill C-420. It is a very important bill for Canadians.
In the 37th Parliament a similar bill made it to second reading with the help of members from all sides of the House. It was at committee stage when the House folded for the election, but during that interval we have already had over 150,000 signatures on petitions in support of the bill. We are still receiving signatures in favour of the bill, which would change the way natural health products are regulated.
I think it is important for Canadians to understand that the bill would still allow for good manufacturing practices and for office and site inspections. We want to make sure that what is on the label is in the bottle and that the appropriate part of the product is still in the product, that is, the active ingredients and so on. That is part of the bill.
Because the member did not have time to bring it up in his speech, I want to draw attention to a study done by the Fraser Institute on this very thing. They discussed Canada's proposed regulatory framework on natural health products in light of international evidence. The study was called “A Cure Worse than the Illness”.
The report talks about the safety of natural health products and points out, as the member has, that the risk factor is so low with natural health products. With the some 60,000 natural health products that Canadians consume, there are fewer serious adverse reactions than there are to Aspirin or Tylenol alone.
The member mentioned melatonin. I know that with his experience as a health care practitioner he would be aware of the benefits of chromium picolinate for diabetics and folic acid for cardiovascular disease. Would he care to comment on the safety of natural health products and some of the benefits that he has observed in his own practice as a health care practitioner?